GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (OTCPK:SGIOF) » Definitions » Cyclically Adjusted Price-to-FCF

Shionogi (Shionogi) Cyclically Adjusted Price-to-FCF : 21.95 (As of Apr. 30, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Shionogi Cyclically Adjusted Price-to-FCF?

As of today (2024-04-30), Shionogi's current share price is $49.60. Shionogi's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $2.26. Shionogi's Cyclically Adjusted Price-to-FCF for today is 21.95.

The historical rank and industry rank for Shionogi's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SGIOF' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 16.76   Med: 22.51   Max: 38.3
Current: 22.01

During the past years, Shionogi's highest Cyclically Adjusted Price-to-FCF was 38.30. The lowest was 16.76. And the median was 22.51.

SGIOF's Cyclically Adjusted Price-to-FCF is ranked better than
64.53% of 327 companies
in the Drug Manufacturers industry
Industry Median: 32.38 vs SGIOF: 22.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Shionogi's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $0.295. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $2.26 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shionogi Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Shionogi's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shionogi Cyclically Adjusted Price-to-FCF Chart

Shionogi Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 20.29 18.69 25.65 17.24

Shionogi Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.86 17.24 17.40 19.72 20.48

Competitive Comparison of Shionogi's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Shionogi's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shionogi's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shionogi's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shionogi's Cyclically Adjusted Price-to-FCF falls into.



Shionogi Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Shionogi's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=49.60/2.26
=21.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shionogi's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Shionogi's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.295/106.8000*106.8000
=0.295

Current CPI (Dec. 2023) = 106.8000.

Shionogi Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.000 95.700 0.000
201406 0.000 98.000 0.000
201409 0.000 98.500 0.000
201412 0.000 97.900 0.000
201503 0.000 97.900 0.000
201506 0.000 98.400 0.000
201509 0.000 98.500 0.000
201512 0.000 98.100 0.000
201603 0.000 97.900 0.000
201606 0.000 98.100 0.000
201609 0.000 98.000 0.000
201612 0.000 98.400 0.000
201703 0.000 98.100 0.000
201706 0.000 98.500 0.000
201709 0.000 98.800 0.000
201712 0.000 99.400 0.000
201803 0.000 99.200 0.000
201806 0.000 99.200 0.000
201809 0.000 99.900 0.000
201812 0.000 99.700 0.000
201903 0.000 99.700 0.000
201906 0.845 99.800 0.904
201909 0.811 100.100 0.865
201912 0.539 100.500 0.573
202003 1.414 100.300 1.506
202006 0.336 99.900 0.359
202009 0.866 99.900 0.926
202012 0.152 99.300 0.163
202103 0.966 99.900 1.033
202106 0.550 99.500 0.590
202109 0.824 100.100 0.879
202112 0.280 100.100 0.299
202203 0.427 101.100 0.451
202206 0.493 101.800 0.517
202209 0.166 103.100 0.172
202212 1.375 104.100 1.411
202303 1.494 104.400 1.528
202306 0.602 105.200 0.611
202309 0.196 106.200 0.197
202312 0.295 106.800 0.295

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shionogi  (OTCPK:SGIOF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Shionogi Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Shionogi's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shionogi (Shionogi) Business Description

Traded in Other Exchanges
Address
1-8, Doshomachi 3-chome, Chuo-ku, Osaka, JPN, 541-0045
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Shionogi (Shionogi) Headlines

From GuruFocus

Shionogi & Co Ltd R&D Meeting Transcript

By GuruFocus Research 02-14-2024

Shionogi & Co Ltd R&D Meeting Transcript

By GuruFocus Research 02-14-2024